Development of the basophil activation test.

Development of the basophil activation test. - basophil activation test

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON32817

Enrollment

Registered

2008-12-16

Start date

2008-09-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anaphylaxis fast allergic reaction type 1 allergy

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Type 1 allergie for diclofenac, benzophenon-3 or birch pollen.

Exclusion criteria

Exclusion criteria: Use of immunomodulatory medicine. Current infectious disease or fever.

Design outcomes

Primary

Measure	Time frame
Reactors to the oral provocation test for diclofenac or to other allergy-tests for subjects allergic to the other allergens are expected to have a greater reaction to the basophil activation test than non-reactors.	—

Countries

Netherlands

Outcome results